Abiopharma

🔍 KAO JOHN E (Director)

Company: Alignment Healthcare, Inc. (ALHC)

Report Date: 2026-03-13

Detailed Transactions and Holdings:

• Acquired 338,434 shares of Common Stock (Direct)
  Date: 2026-03-13 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,857,914.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-13 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 2,472,641.00 | Footnotes: F2

Footnotes:

• F1: Represents 338,434 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.
• F2: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.